News for Healthier Living
Timing of Shingles Vaccine and JAK Inhibitor Initiation Can Affect Early Outcomes in Patients with Rheumatoid Arthritis
A randomized trial in patients with rheumatoid arthritis (RA) suggests that the timing of when a Janus kinase (JAK) inhibitor is initiated relative to administration of the shingles vaccine can affect early immune response to shingles and arthritis control.
July 20, 2026
July 25 2026July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026July 17 2026July 16 2026July 15 2026July 14 2026July 13 2026July 12 2026
|
|
|
|
|